{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:08:04Z","timestamp":1784570884825,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:00:00Z","timestamp":1503619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:00:00Z","timestamp":1503619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Influenza virus infections are serious public health concerns throughout the world. The development of compounds with novel mechanisms of action is urgently required due to the emergence of viruses with resistance to the currently-approved anti-influenza viral drugs. We performed<jats:italic>in silico<\/jats:italic>screening using a structure-based drug discovery algorithm called Nagasaki University Docking Engine (NUDE), which is optimised for a GPU-based supercomputer (DEstination for Gpu Intensive MAchine; DEGIMA), by targeting influenza viral PA protein. The compounds selected by NUDE were tested for anti-influenza virus activity using a cell-based assay. The most potent compound, designated as PA-49, is a medium-sized quinolinone derivative bearing a tetrazole moiety, and it inhibited the replication of influenza virus A\/WSN\/33 at a half maximal inhibitory concentration of 0.47\u2009\u03bcM. PA-49 has the ability to bind PA and its anti-influenza activity was promising against various influenza strains, including a clinical isolate of A(H1N1)pdm09 and type B viruses. The docking simulation suggested that PA-49 interrupts the PA\u2013PB1 interface where important amino acids are mostly conserved in the virus strains tested, suggesting the strain independent utility. Because our NUDE\/DEGIMA system is rapid and efficient, it may help effective drug discovery against the influenza virus and other emerging viruses.<\/jats:p>","DOI":"10.1038\/s41598-017-10021-w","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T14:17:35Z","timestamp":1503325055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Structure-based drug discovery for combating influenza virus by targeting the PA\u2013PB1 interaction"],"prefix":"10.1038","volume":"7","author":[{"given":"Ken","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-1381","authenticated-orcid":false,"given":"Takeshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-8434","authenticated-orcid":false,"given":"Hiroki","family":"Otaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Nakagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzo","family":"Urata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,25]]},"reference":[{"key":"10021_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nrd2175","volume":"5","author":"E De Clercq","year":"2006","unstructured":"De Clercq, E. Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 5, 1015\u20131025 (2006).","journal-title":"Nat Rev Drug Discov"},{"key":"10021_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.coviro.2011.09.002","volume":"1","author":"MG Ison","year":"2011","unstructured":"Ison, M. G. Antivirals and resistance: influenza virus. Curr Opin Virol 1, 563\u2013573 (2011).","journal-title":"Curr Opin Virol"},{"key":"10021_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jcv.2009.11.003","volume":"47","author":"T Baranovich","year":"2010","unstructured":"Baranovich, T. et al. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008\u20132009 season. J Clin Virol 47, 23\u201328 (2010).","journal-title":"J Clin Virol"},{"key":"10021_CR4","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jama.2009.294","volume":"301","author":"NJ Dharan","year":"2009","unstructured":"Dharan, N. J. et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301, 1034\u20131041 (2009).","journal-title":"JAMA"},{"key":"10021_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3201\/eid1504.181280","volume":"15","author":"A Meijer","year":"2009","unstructured":"Meijer, A. et al. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007\u201308 season. Emerg Infect Dis 15, 552\u2013560 (2009).","journal-title":"Emerg Infect Dis"},{"key":"10021_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrmicro.2016.87","volume":"14","author":"AJ Te Velthuis","year":"2016","unstructured":"Te Velthuis, A. J. & Fodor, E. Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol 14, 479\u2013493 (2016).","journal-title":"Nat Rev Microbiol"},{"key":"10021_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/rmv.575","volume":"18","author":"K Nagata","year":"2008","unstructured":"Nagata, K., Kawaguchi, A. & Naito, T. Host factors for replication and transcription of the influenza virus genome. Rev Med Virol 18, 247\u2013260 (2008).","journal-title":"Rev Med Virol"},{"key":"10021_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0092-8674(91)90576-K","volume":"67","author":"K Martin","year":"1991","unstructured":"Martin, K. & Helenius, A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67, 117\u2013130 (1991).","journal-title":"Cell"},{"key":"10021_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrmicro3367","volume":"13","author":"AJ Eisfeld","year":"2015","unstructured":"Eisfeld, A. J., Neumann, G. & Kawaoka, Y. At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol 13, 28\u201341 (2015).","journal-title":"Nat Rev Microbiol"},{"key":"10021_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","volume":"100","author":"Y Furuta","year":"2013","unstructured":"Furuta, Y. et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res 100, 446\u2013454 (2013).","journal-title":"Antiviral Res"},{"key":"10021_CR11","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1128\/JVI.76.18.8989-9001.2002","volume":"76","author":"E Fodor","year":"2002","unstructured":"Fodor, E. et al. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J Virol 76, 8989\u20139001 (2002).","journal-title":"J Virol"},{"key":"10021_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1348-0421.2003.tb03413.x","volume":"47","author":"K Hara","year":"2003","unstructured":"Hara, K. et al. Inhibition of the protease activity of influenza virus RNA polymerase PA subunit by viral matrix protein. Microbiol Immunol 47, 521\u2013526 (2003).","journal-title":"Microbiol Immunol"},{"key":"10021_CR13","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","volume":"96","author":"G Neumann","year":"1999","unstructured":"Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96, 9345\u20139350 (1999).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10021_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00430-014-0349-y","volume":"204","author":"J Hu","year":"2015","unstructured":"Hu, J. & Liu, X. Crucial role of PA in virus life cycle and host adaptation of influenza A virus. Med Microbiol Immunol 204, 137\u2013149 (2015).","journal-title":"Med Microbiol Immunol"},{"key":"10021_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nature07225","volume":"454","author":"E Obayashi","year":"2008","unstructured":"Obayashi, E. et al. The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature 454, 1127\u20131131 (2008).","journal-title":"Nature"},{"key":"10021_CR16","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/emboj.2009.138","volume":"28","author":"K Sugiyama","year":"2009","unstructured":"Sugiyama, K. et al. Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase. EMBO J 28, 1803\u20131811 (2009).","journal-title":"EMBO J"},{"key":"10021_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature14008","volume":"516","author":"A Pflug","year":"2014","unstructured":"Pflug, A., Guilligay, D., Reich, S. & Cusack, S. Structure of influenza A polymerase bound to the viral RNA promoter. Nature 516, 355\u2013360 (2014).","journal-title":"Nature"},{"key":"10021_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1246\/cl.2011.801","volume":"40","author":"L Li","year":"2011","unstructured":"Li, L. et al. Screening anti-influenza agents that target avian influenza polymerase protein PAC from plant extracts based on NMR methods. Chem Lett 40, 801\u2013803 (2011).","journal-title":"Chem Lett"},{"key":"10021_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007517","volume":"4","author":"K Wunderlich","year":"2009","unstructured":"Wunderlich, K. et al. Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. PLoS One 4, e7517 (2009).","journal-title":"PLoS One"},{"key":"10021_CR20","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1016\/j.bmcl.2013.08.048","volume":"23","author":"U Kessler","year":"2013","unstructured":"Kessler, U. et al. Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus. Bioorg Med Chem Lett 23, 5575\u20135577 (2013).","journal-title":"Bioorg Med Chem Lett"},{"key":"10021_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.antiviral.2015.11.005","volume":"125","author":"S Yuan","year":"2016","unstructured":"Yuan, S. et al. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase. Antiviral Res 125, 34\u201342 (2016).","journal-title":"Antiviral Res"},{"key":"10021_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/1074-5521(95)90050-0","volume":"2","author":"DK Gehlhaar","year":"1995","unstructured":"Gehlhaar, D. K. et al. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. Chem Biol 2, 317\u2013324 (1995).","journal-title":"Chem Biol"},{"key":"10021_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"M von Itzstein","year":"1993","unstructured":"von Itzstein, M. et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418\u2013423 (1993).","journal-title":"Nature"},{"key":"10021_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ebiom.2016.06.010","volume":"9","author":"D Ishibashi","year":"2016","unstructured":"Ishibashi, D. et al. Structure-based drug discovery for prion disease using a novel binding simulation. EBioMedicine 9, 238\u2013249 (2016).","journal-title":"EBioMedicine"},{"key":"10021_CR25","doi-asserted-by":"crossref","unstructured":"Makau, J. N. et al. Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches. PLoS One 12, e0173582 (2017).","DOI":"10.1371\/journal.pone.0173582"},{"key":"10021_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbagen.2011.11.003","volume":"1820","author":"M Fukuoka","year":"2012","unstructured":"Fukuoka, M. et al. Structure-based discovery of anti-influenza virus A compounds among medicines. Biochim Biophys Acta 1820, 90\u201395 (2012).","journal-title":"Biochim Biophys Acta"},{"key":"10021_CR27","doi-asserted-by":"publisher","first-page":"9144","DOI":"10.1128\/JVI.78.17.9144-9153.2004","volume":"78","author":"E Fodor","year":"2004","unstructured":"Fodor, E. & Smith, M. The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex. J Virol 78, 9144\u20139153 (2004).","journal-title":"J Virol"},{"key":"10021_CR28","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/jcp.39.6.672","volume":"39","author":"SW Rothman","year":"1986","unstructured":"Rothman, S. W. Technique for measuring 50% end points in cytotoxicity assays for Clostridium difficile toxins. J Clin Pathol 39, 672\u2013676 (1986).","journal-title":"J Clin Pathol"},{"key":"10021_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.arcmed.2014.12.002","volume":"46","author":"S Charyasriwong","year":"2015","unstructured":"Charyasriwong, S. et al. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection. Arch Med Res 46, 8\u201316 (2015).","journal-title":"Arch Med Res"},{"key":"10021_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1128\/AAC.17.5.865","volume":"17","author":"FG Hayden","year":"1980","unstructured":"Hayden, F. G., Cote, K. M. & Douglas, R. G. Jr. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother 17, 865\u2013870 (1980).","journal-title":"Antimicrob Agents Chemother"},{"key":"10021_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005636","volume":"12","author":"J Reguera","year":"2016","unstructured":"Reguera, J. et al. Comparative structural and functional analysis of bunyavirus and arenavirus cap-snatching endonucleases. PLoS Pathog 12, e1005636 (2016).","journal-title":"PLoS Pathog"},{"key":"10021_CR32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4161\/rna.20345","volume":"9","author":"PJ Kranzusch","year":"2012","unstructured":"Kranzusch, P. J. & Whelan, S. P. Architecture and regulation of negative-strand viral enzymatic machinery. RNA Biol 9, 941\u2013948 (2012).","journal-title":"RNA Biol"},{"key":"10021_CR33","doi-asserted-by":"publisher","first-page":"10651","DOI":"10.1128\/JVI.07244-11","volume":"86","author":"LT Pinilla","year":"2012","unstructured":"Pinilla, L. T., Holder, B. P., Abed, Y., Boivin, G. & Beauchemin, C. A. The H275Y neuraminidase mutation of the pandemic A\/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets. J Virol 86, 10651\u201310660 (2012).","journal-title":"J Virol"},{"key":"10021_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsps.2012.03.002","volume":"21","author":"A Marella","year":"2013","unstructured":"Marella, A. et al. Quinoline: A versatile heterocyclic. Saudi Pharm J 21, 1\u201312 (2013).","journal-title":"Saudi Pharm J"},{"key":"10021_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.2042-7158.1978.tb13228.x","volume":"30","author":"S Yamashita","year":"1978","unstructured":"Yamashita, S., Takai, M. & Yabuuchi, Y. Actions of procaterol (OPC-2009), a new beta2-adrenoceptor stimulant, on pulmonary resistance, contractions of the soleus muscle, and cardiovascular system of the anaesthetized cat. J Pharm Pharmacol 30, 273\u2013279 (1978).","journal-title":"J Pharm Pharmacol"},{"key":"10021_CR36","first-page":"1124","volume":"35","author":"H Akiyama","year":"1985","unstructured":"Akiyama, H., Kudo, S. & Shimizu, T. The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man. Arzneimittelforschung 35, 1124\u20131132 (1985).","journal-title":"Arzneimittelforschung"},{"key":"10021_CR37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3565(25)10600-9","volume":"274","author":"T Kikuchi","year":"1995","unstructured":"Kikuchi, T. et al. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinon e (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. J Pharmacol Exp Ther 274, 329\u2013336 (1995).","journal-title":"J Pharmacol Exp Ther"},{"key":"10021_CR38","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1021\/jm101202j","volume":"54","author":"SM Stanford","year":"2011","unstructured":"Stanford, S. M. et al. Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. J Med Chem 54, 1640\u20131654 (2011).","journal-title":"J Med Chem"},{"key":"10021_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46, 3\u201326 (2001).","journal-title":"Adv Drug Deliv Rev"},{"key":"10021_CR40","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.micinf.2012.02.012","volume":"14","author":"K Yamada","year":"2012","unstructured":"Yamada, K. et al. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase. Microbes Infect 14, 740\u2013747 (2012).","journal-title":"Microbes Infect"},{"key":"10021_CR41","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1021\/acs.jmedchem.5b00012","volume":"58","author":"S Massari","year":"2015","unstructured":"Massari, S. et al. A broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits. J Med Chem 58, 3830\u20133842 (2015).","journal-title":"J Med Chem"},{"key":"10021_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/tcr.201300026","volume":"13","author":"J Ohkanda","year":"2013","unstructured":"Ohkanda, J. Module assembly for designing multivalent mid-sized inhibitors of protein-protein interactions. Chem Rec 13, 561\u2013575 (2013).","journal-title":"Chem Rec"},{"key":"10021_CR43","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1158\/1078-0432.CCR-09-1023","volume":"15","author":"A Jimeno","year":"2009","unstructured":"Jimeno, A. Eribulin: rediscovering tubulin as an anticancer target. Clin Cancer Res 15, 3903\u20133905 (2009).","journal-title":"Clin Cancer Res"},{"key":"10021_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers, A. J. et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19, 202\u2013208 (2013).","journal-title":"Nat Med"},{"key":"10021_CR45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/1097-0134(20010501)43:2<186::AID-PROT1030>3.0.CO;2-L","volume":"43","author":"N Gibbs","year":"2001","unstructured":"Gibbs, N., Clarke, A. R. & Sessions, R. B. Ab initio protein structure prediction using physicochemical potentials and a simplified off-lattice model. Proteins 43, 186\u2013202 (2001).","journal-title":"Proteins"},{"key":"10021_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open Babel: An open chemical toolbox. J Cheminform 3, 33 (2011).","journal-title":"J Cheminform"},{"key":"10021_CR47","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J Comput Chem 25, 1157\u20131174 (2004).","journal-title":"J Comput Chem"},{"key":"10021_CR48","first-page":"189","volume":"7","author":"JN Makau","year":"2013","unstructured":"Makau, J. N., Watanabe, K. & Kobayashi, N. Anti-influenza activity of Alchemilla mollis extract: possible virucidal activity against influenza virus particles. Drug Discov Ther 7, 189\u2013195 (2013).","journal-title":"Drug Discov Ther"},{"key":"10021_CR49","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.4161\/auto.25381","volume":"9","author":"T Nakagaki","year":"2013","unstructured":"Nakagaki, T. et al. FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice. Autophagy 9, 1386\u20131394 (2013).","journal-title":"Autophagy"},{"key":"10021_CR50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5582\/ddt.2013.v7.6.254","volume":"7","author":"T Ichinose","year":"2013","unstructured":"Ichinose, T., Musyoka, T. M., Watanabe, K. & Kobayashi, N. Evaluation of antiviral activity of Oligonol, an extract of Litchi chinensis, against betanodavirus. Drug Discov Ther 7, 254\u2013260 (2013).","journal-title":"Drug Discov Ther"},{"key":"10021_CR51","unstructured":"Case, D. A. et al. AMBER 10. (University of California, San Francisco, CA, 2008)."},{"key":"10021_CR52","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak, V. et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65, 712\u2013725 (2006).","journal-title":"Proteins"},{"key":"10021_CR53","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J Comput Chem 25, 1605\u20131612 (2004).","journal-title":"J Comput Chem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10021-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:47:22Z","timestamp":1750808842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10021-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,25]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10021"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10021-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,25]]},"assertion":[{"value":"3 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9500"}}